Veeva Systems Gains on New Top 20 Biopharma Customer
Veeva Systems (VEEV) saw its stock rise after announcing that a top 20 biopharmaceutical company has selected Vault CRM, the firm's customer relationship management platform. The deal marks Veeva’s continued expansion in the life sciences sector and reinforces confidence in its cloud-based solutions for pharmaceutical clients. The announcement comes as part of broader adoption by major players in the industry; now 14 out of the top 20 biopharma companies have chosen Vault CRM, according to Veeva. This growing market penetration highlights increasing demand for digital transformation tools within pharma and biotech firms.
Tickers: $VEEV